Lisdexamfetamine dimesylate (Vyvanse) for ADHD
- PMID: 17637583
Lisdexamfetamine dimesylate (Vyvanse) for ADHD
Similar articles
-
Lisdexamfetamine dimesylate for childhood ADHD.Drugs Today (Barc). 2008 May;44(5):319-24. doi: 10.1358/dot.2008.44.5.1215724. Drugs Today (Barc). 2008. PMID: 18548134 Review.
-
Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder.J Clin Psychiatry. 2009 Dec;70(12):1652-61. doi: 10.4088/JCP.09m05335pur. J Clin Psychiatry. 2009. PMID: 20141706 Clinical Trial.
-
Lisdexamfetamine for treatment of attention-deficit/hyperactivity disorder.Ann Pharmacother. 2009 Apr;43(4):669-76. doi: 10.1345/aph.1L521. Epub 2009 Mar 24. Ann Pharmacother. 2009. PMID: 19318601 Review.
-
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.J Clin Psychiatry. 2012 Jul;73(7):977-83. doi: 10.4088/JCP.11m07430. Epub 2012 Jun 12. J Clin Psychiatry. 2012. PMID: 22780921 Clinical Trial.
-
The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.Clin Ther. 2009 Jan;31(1):142-76. doi: 10.1016/j.clinthera.2009.01.015. Clin Ther. 2009. PMID: 19243715 Review.
Cited by
-
Psychopharmacology of ADHD in pediatrics: current advances and issues.Neuropsychiatr Dis Treat. 2009;5:171-81. doi: 10.2147/ndt.s4075. Epub 2009 Apr 8. Neuropsychiatr Dis Treat. 2009. PMID: 19557112 Free PMC article.
-
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev. 2016 Feb 4;2(2):CD009996. doi: 10.1002/14651858.CD009996.pub2. Cochrane Database Syst Rev. 2016. PMID: 26844979 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical